| Original language | English (US) |
|---|---|
| Pages (from-to) | 285-292 |
| Number of pages | 8 |
| Journal | Surgical Pathology Clinics |
| Volume | 14 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jun 2021 |
Funding
This study was supported by the IDP Foundation, Inc. Dr P. Gerami has served as a consultant for Myriad Genomics, DermTech Int. Merck, and Castle Biosciences, and has received honoraria for all. All other authors report no relevant conflicts of interest. This work is original and has not been previously published. Dr P. Gerami has served as a consultant for Myriad Genomics, DermTech Int., Merck, and Castle Biosciences, and has received honoraria for all. All other authors report no relevant conflicts of interest. This work is original and has not been previously published. This study was supported by the IDP Foundation, Inc.
Keywords
- Epithelioid
- Melanocytoma
- Molecular pathology
- PRKAR1A mutation
- PRKCA fusion
- Pigmented epithelioid melanocytoma
ASJC Scopus subject areas
- Surgery
- Pathology and Forensic Medicine